NL-OMON53538RecruitingNot Applicable
Objective Neurocognitive assessment of young children with sickle cell disease by eye-tracking - ONSET
Amsterdam UMC0 sites100 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 0 to 11 (—)
Inclusion Criteria
- •- Diagnosis of SCD (SCD group);
- •- Age 6 - 24 months old;
- •- Inhabitant of the Netherlands;
- •- Written informed consent from parent/caretaker;
Exclusion Criteria
- •- Refused informed consent from parents/care-taker;
- •- Diagnosis of visual impairment;
- •- Diagnosis of a (co-morbid) congenital developmental condition
- •- Any neurological condition, unrelated to SCD, that could affect the central
- •nervous system, such as brain trauma, epilepsy and meningitis/encephalitis.
Investigators
Similar Trials
Completed
Not Applicable
Saving Brains: the Artesunate Suppository Severe Malaria CohortISRCTN73295852Mahidol Oxford Tropical Medicine Research Unit (MORU) (Thailand)6,000
Not yet recruiting
Not Applicable
Investigation of cognitive characteristic of children with reading difficulties.developmental dyslexiaJPRN-UMIN000029277Osaka Medical Collage30
Completed
Not Applicable
Cognitive development of early infancy assessed with near-infrared spectroscopyChildJPRN-UMIN000021073Keio University Shcool of Medicine150
Completed
Not Applicable
The neurocognitive development of infants and young childregeen betrekking op aandoeningen, het gaat om niet-therapeutisch, groepsgebonden onderzoekNL-OMON37377Radboud Universiteit Nijmegen1,000
Active, not recruiting
Not Applicable
Micronutrient interventions to improve infant neurocognitive development and growth in early infancyInfant neurocognitive development and growthISRCTN15063705King's College London600